A B S T R A C T The influence of calcitonin (CT) on various stages of bone formation was investigated. A demineralized collagenous bone matrix-induced bone forming system in rats was used to temporally segregate chondrogenesis and osteogenesis. Administration of CT (15 Medical Research Council Units [MRCU]) daily) at the initiation of matrix-induced bone formation (BF) resulted in a 76% stimulation of BF as measured by 45Ca incorporation and alkaline phosphatase activity. This increase was due, in part, to a stimulation of cartilage and bone precursor cell proliferation monitored by the rate of [3H]thymidine incorporation and ornithine decarboxylase activity. Chondrogenesis on day 7 as measured by 35SO4 incorporation was increased by 52% with CT treatment. To rule out the possibility of a secondary response due to parathyroid hormone, similar studies were done in parathyroidectomized animals and CT stimulation of BF was still observed. However, when CT injections were started after cartilage formation (day 8) there was no stimulation of BF but a significant decrease in 45Ca incorporation was observed. These results indicate CT has two actions: (a) when CT is administered during the initial phases of bone formation, it increases BF due to a stimulation of proliferation of cartilage and bone precursor cells; and (b) when CT is administered after bone formation has been initiated, subsequent bone formation is suppressed.
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INTRODUCTION
It has been well documented that calcitonin (CT)1 can inhibit osteoclastic bone resorption (1, 2) and per- haps osteocytic osteolysis (3) (4) (5) . However, the role of CT in osteoblastic bone formation is controversial. Some investigators have found that pharmacologic doses of CT are without effect on bone formation (6), while others have found it is stimulatory (7-9) or inhibitory (10) . To determine the influence of CT on developing cartilage, bone and bone marrow, a demineralized collagenous bone matrix-induced endochondral bone-forming system was used (11, 12) . This permitted the temporal segregation of the various stages of bone formation and allowed us to examine the influence of CT on each of the phases.
METHODS
Demineralized bone matrix prepared from rat diaphyses was implanted subcutaneously in the thoracic region into 21-23 d-old male rats, Long Evans strain (75-85 g). The day of implantation was designated as day 0. The present study investigated the influence of salmon calcitonin, 15 MRCU subcutaneous injections daily, (Calcimar, Armour Pharmaceuticals, Scottsdale, Ariz.) on four distinct phases of matrixinduced bone formation (11) in treated and untreated control rats: (a) proliferation of mesenchymal cells 3 d after implantation by [3H]thymidine incorporation (13) and ornithine decarboxylase (ODC) activity (14, 15) ; (b) chondrogenesis on day 7, monitored by 35SO4 incorporation into proteoglycans (11, 12) ; (c) osteogenesis on day 14 monitored by 45Ca incorporation (11, 12) ; and (d) bone marrow formation was monitored by 59Fe incorporation on day 21, (11, 12) . The tissue activities of alkaline and acid phosphatases (11) were determined because of their close association with bone formation and resorption, respectively. Beta-glucuronidase was also measured in the developing tissues as a marker for lysosomal enzyme release (15) . Two plaques (implants) from each rat were assayed in duplicate, and there were four rats in each experimental group and control group. Epiphyseal growth plates were also assayed in the CT-treated and untreated control rats. chondroprogenitor cells and another peak on day 9, corresponding to the proliferation of osteoprogenitor cells. In those animals treated daily with CT there was a two-and fourfold increase of [3H]thymidine and ODC activity, respectively, on day 3. Chondrogenesis as measured by the rate of 35SO4 into proteoglyeans was increased by 52% in those animals treated daily with injections of CT. There was a 55% increase in the rate of 35SO4 incorporation in the epiphyseal growth plate. The rate of 45Ca incorporation was markedly increased in the CT-treated animals (Fig. 2a) . Tissue alkaline phosphatase (Fig. 2b) was also increased in activity in those animals injected with CT. A 76% increase in activity was observed on day 14. Acid phosphatase (Fig. 2c ) and beta-glucuronidase (Fig. 2d) were both inhibited by CT treatment during the initial 11 d. These enzymes, which are found in osteoclasts, are markers of bone resorption. The findings of inhibited activity of acid phosphatase and betaglucuronidase agrees with the acknowledged inhibitory effect of CT on osteoclastic resorption. The monitoring of bone marrow formation by the rate of incorporation of 59Fe revealed there was no stimulation or inhibition of marrow formation with daily injections. Analysis of osteogenesis in parathyroidectomized rats showed that CT stimulated bone formation to the same degree as in nonparathyroidectomized control rats (Table I) . Therefore, one can rule out the possibility that observed stimulation of bone formation is due to increased parathyroid hormone secretion.
The stage of tissue development determined the nature of the tissue response to CT (Fig. 3) . If CT was administered daily at the onset of bone induction, BF was stimulated as we have described above. However, when daily CT administration was not begun until day 8 following implantation, subsequently there was an inhibition (32%) of bone formation. This indicates that if CT is given after bone formation has been initiated the stimulatory effect was abolished. On the other hand if CT was given at the time of implantation and then stopped prior to bone differentiation (day 8) , there was no observed stimulation or inhibition of bone formation (Fig. 3) .
The observation that CT can stimulate bone formation when administered at the initiation of bone formation suggests that this hormone may play a role in the developmental processes of the skeleton. The suppression of bone formation when CT is given after the initiation of osteogenesis is similar to the observed clinical patterns of decreased bone formation when the hormone is administered to patients with various bone diseases. While there is much controversy in the literature concerning the utility of CT in enhancing the rate of fracture repair, our results with the bone matrix-induced bone forming model paradoxical effects of CT on matrix-induced endochondral bone formation. There are several possible explanations for the stimulatory effects of CT on osteogenesis. Osteoblast precursor cells may have a large number of CT receptors or higher affinity receptors compared to differentiated osteoblasts. Alternatively, the receptors may be similar in both osteoblast precursors and differentiated osteoblasts, but it is possible that differences in postreceptor events may account for the paradoxical effects. In addition one cannot rule out the possibility that CT treatment may stimulate bone formation indirectly via stimulation of la,25-dihydroxyvitamin D (16) . Finally, it is well known that bone homeostasis is maintained by a balance between resorption and formation and that these two processes are closely coupled (10) . Therefore the apparent inhibitory effect of CT on differentiated osteoblasts may not arise as a direct effect of the hormone. CT is known to inhibit the activity of osteoclasts which may result in a concommitant inhibition of bone formation through the regulation of local factors (17) .
